Pediatric Myeloproliferative Neoplasms

809) and thorax (k=0.756). Low dose computed tomography/PET sensitivity, specificity and accuracy were 89.4%, 98.3% and 93.5%, respectively.
Low dose computed tomography co-registered PET has comparable performance to WBLDCT. If confirmed on a lager sample, these encouraging results suggest the possibility to use this multimodal hybrid imaging as the only method for MM evaluation, rather than both exams, providing both morphologic and metabolic information in one session with impact on patient compliance, health care spending and especially radiation exposure.
Low dose computed tomography co-registered PET has comparable performance to WBLDCT. If confirmed on a lager sample, these encouraging results suggest the possibility to use this multimodal hybrid imaging as the only method for MM evaluation, rather than both exams, providing both morphologic and metabolic information in one session with impact on patient compliance, health care spending and especially radiation exposure.
The diagnosis, treatment, and management of the breast cancer (BC) require a multidisciplinary approach. In newly diagnosed BC, fluorine-18-fluorodeoxyglucose positron emission tomography (
F-FDG PET) can detect extra-axillary regional nodal and distant lesions.
Between 2010 and 2015, this study included 101 patients with early-stage BC who were examined with
F-FDG PET before surgery. Patients were divided into two groups Group 1 consisted of patients with suspected
F-FDG uptake and Group 2 with the remaining
F-FDG-negative patients. Differences between these groups were tested using the Pearson chi-square test, Fisher's exact test, Mann Whitney-U test, independent t-test and ROC analysis. They could be followed-up after 2015 for 5 years. All patients were then rediscussed either neoadjuvant therapy or surgery in the oncology board in 2020 with changing neoadjuvant criteria and oncoplastic surgery techniques.
Fluorine-18-FDG PET was found to have a sensitivity of 77.8% and a specificity of 90.8% FDG PET demonstrated better performance in axillary lymph nodes metastases detection in comparison with other diagnostic imaging methods, even if SLNB remains the gold standard technique.
Geriatric patients are often reluctant to undergo parathyroid surgery under general anesthesia because of the major comorbidities. The use of minimally invasive techniques for parathyroid lesions under local anesthesia have been published. Radioguided lesion localization has been known to decrease operative time and reduce the occurrence of positive margins in breast cancer surgery. We hypothesize that it could also be effectively used in focused parathyroid surgery in geriatric patients with in history of thyroid surgery.
Our study group consists of geriatric patients with a history of thyroid surgery who underwent focused parathyroid surgery between February 2017 and October 2019. Group-1 included 18 patients who had parathyroidectomy under radioguidance. Group-2, 22 patients who had surgery without it. Patient demographics, operative time, number of frozen sections and length of hospital stay were analyzed.
Analyzed data were similar between groups. The mean age of the patients was 72.56±12.65 years (range 65-88). The operative times for group-1 and group-2, were 65.42±7.78 and 74.63±15.98 minutes, respectively (P=0.002). All patients were discharged uneventfully on postoperative day-2.
Radioguidance parathyroidectomy positively affected the operative time and also decreased the need for additional frozen section.
Radioguidance parathyroidectomy positively affected the operative time and also decreased the need for additional frozen section.
To determine the outcome of iodine-131 (
I) treatment regimens in thyroidectomy patients with differentiated thyroid cancer.
Based on Taiwan's National Health Insurance Research Database (NHIRD) during the period from January 1, 2000 to December 31, 2010, 390 patients with well-differentiated thyroid cancer who underwent
I treatment after thyroidectomy were enrolled in this study. Patients were classified into six groups according to the type of thyroidectomy and initial activity regimen of
I treatment. The clinical outcome of
I treatment was evaluated by total treatment number and medical expenditure, including costs for hospitalization and laboratory tests together with initial and subsequent
I treatments. Multiple linear regression analysis was applied to analyze the factor(s) significantly affecting the outcome of
I treatment.
Increased activity of the initial
I regimen reduced the total treatment number significantly for unilateral total thyroidectomy with initial 100-150mCi
I, and mildly for bilateral total thyroidectomy with initial 100-150mCi
I and radical thyroidectomy with initial 30-99mCi
I. Increased activity of the initial
I regimen reduced total medical expenditure significantly for unilateral, and mildly for bilateral total thyroidectomy both with initial 30-99mCi
I.
For patients with specific thyroidectomy for differentiated thyroid cancer, a high initial regimen of
I treatment is more effective than the low activity regimen. An increased activity of the initial
I regimen significantly reduced the total treatment number and medical expenditure.
For patients with specific thyroidectomy for differentiated thyroid cancer, a high initial regimen of 131I treatment is more effective than the low activity regimen. An increased activity of the initial 131I regimen significantly reduced the total treatment number and medical expenditure.
Gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography (
Ga-PSMA PET/CT) has become a well-established imaging method for the evaluation of patients with prostate cancer. However, several cases have revealed PSMA uptake in a large variety of conditions other than prostate cancer. Prostate-specific membrane antigen uptake in thyroid cancer has also been reported. The aim of the present study was to systematically investigate the prevalence and clinical significance of thyroid incidental findings in patients undergoing
Ga-PSMA PET/CT.
We retrospectively identified all patients referred for
Ga-PSMA PET/CT at the Department of Nuclear Medicine, Aalborg University Hospital, Denmark between May 2015 and May 2019. Patients with increased PSMA uptake in the thyroid gland were included in the analysis. Follow-up included imaging, biochemical, and/or histopathological collected over six months.
A total of 341 patients were included. Increased
Ga-PSMA uptake in the thyroid gland was observed in 13 patients (4%). Focal uptake was observed in seven patients, diffuse uptake in five patients and mixed focal and diffuse uptake in one patient. Malignancy was verified in two patients (2/13 patients, 15%), both patients with focal PSMA uptake.
Gallium-68-PSMA thyroid incidental findings are rare in prostate cancer patients. However, cases of focal PSMA uptake in the thyroid gland should be further investigated, as these findings may represent metastatic or primary malignancy of the thyroid gland.
Gallium-68-PSMA thyroid incidental findings are rare in prostate cancer patients. However, cases of focal PSMA uptake in the thyroid gland should be further investigated, as these findings may represent metastatic or primary malignancy of the thyroid gland.
Lutetium-177 (
Lu) prostate specific membrane antigen (PSMA) radionuclide therapy (RNT) is an effective and safe treatment option in patients with metastatic castration resistant prostate cancer (mCRPC). The first aim of this study was to determine RNT response rate. The second and main aim of this study is measure overall and progression-free survival (OS and PFS) and to determine the factors have effect on OS and PFS.
Patients with mCRPC had
Lu PSMA RNT every 6-8 weeks. Therapy response of each cycle determined wit PSA after 6-8 weeks. Overall survival and PFS were measured, then effects of age, Gleason grade, local recurrence, extraabdominopelvic located lymph node metastasis, visceral metastasis, prostate specific antigen (PSA) changing after the first RNT, pretreatment PSA, hemoglobin (Hb), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) values on survivals were determined.
Forty-five patients were treated with total of 164 cycles of RNT. Fifteen patients (33%) had PSA decline of ≥50%, 23 patients (51%) showed any PSA decline and 20 patients (44%) showed PSA increase of ≥25%. selleckchem Median OS and PFS were 17,1 months and 7,4 months. Patients had any or ≥50% PSA response after the first cycle, lower initial ALP (<120U/L) had longer OS and PFS. Patients had normal Hb showed longer OS and patients had lower initial PSA (<51ng/mL) had longer PFS. Patients had PSA progression of ≥25% had shorter OS and PFS.
Prostate specific antigen response after the first cycle, lower initial ALP is related to longer OS and PFS. Normal pretreatment Hb is a predictor of longer OS and lower initial PSA is related to longer PFS. Prostate specific antigen progression after the first cycle causes shorter OS and PFS.
Prostate specific antigen response after the first cycle, lower initial ALP is related to longer OS and PFS. Normal pretreatment Hb is a predictor of longer OS and lower initial PSA is related to longer PFS. Prostate specific antigen progression after the first cycle causes shorter OS and PFS.
The aim of this study was to validate the optimal scatter correction method and scatter estimation window setting in terms of image quality and quantitative accuracy for quantitative indium-111 (
In)-pentetreotide SPECT imaging.
We used a positron emission tomography/computed tomography (PET/CT) phantom to validate image quality and quantitative accuracy, and the SPECT images were acquired by the multi-energy window (MEW) method. The scatter estimation was performed using four kinds of energy windows (MEW1, MEW2, MEW3, and MEW4). Scatter correction was also performed using a dual-energy window (DEW) for comparison with MEWs. Image quality was assessed using percent contrast (% contrast) and background variability, and quantitative accuracy was assessed using the mean standardized uptake value (SUVmean) with hot spheres.
In the quantification, all MEW settings approached the theoretical SUVmean (MEW1, 0.99±0.06; MEW2, 0.99±0.05; MEW3, 1.00±0.08; MEW4, 0.97±0.12) in contrast to DEW (0.88±0.05). The SUVmean value for scatter correction of both photopeaks for a 28 mm sphere showed the smallest difference from the theoretical value.
The scatter correction method that gave optimal image quality and quantitative accuracy was MEW3 with two 20% energy windows (one over each photopeak) and four adjacent 3% scatter estimation windows (one on each side of the two photopeaks).
The scatter correction method that gave optimal image quality and quantitative accuracy was MEW3 with two 20% energy windows (one over each photopeak) and four adjacent 3% scatter estimation windows (one on each side of the two photopeaks).
The coronavirus disease of 2019 (COVID-19) represents a difficult challenge and could have devastating consequences for the healthcare system and healthcare workers in war-torn countries with poor healthcare facilities such as Yemen. Our study aimed to evaluate the knowledge, preparedness, counselling practices of healthcare workers regarding COVID-19, and the perceived barriers to adequately prevent and control COVID-19 in Yemen.
Healthcare workers (HCWs) from major healthcare facilities participated in this cross-sectional study. A self-administered questionnaire comprising of five main domains (demographics, knowledge, self-preparedness, counselling practice, perceived barriers) was distributed among HCWs after obtaining informed consent. A convenient sampling technique was used. Descriptive and inferential analyses were applied using SPSS software.
A total of 1000 participants were initially targeted to participate in the study with 514 (51.4%) responding, of which 55.3% were female. Physicians and nurses constituted the largest proportion of participants, with 39.